Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

Authors

Institutions

Publication Details

Journal
Breast Cancer Research and Treatment
Published
2024-12-03
DOI
https://doi.org/10.1007/s10549-024-07555-9
Citations
1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

W. Fraser Symmans, Angela M. DeMichele, Michael J. Campbell, Amy Wilson et al.
1 citations
Breast Cancer Research and Treatment
HER2/EGFR in Cancer Research
0.28
article

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

W. Fraser Symmans, Angela M. DeMichele, Michael J. Campbell, Amy Wilson, Ruby Singhrao, Judy C. Boughey, Douglas Yee, Nola M. Hylton, Katherine Steeg, Julia L. Clennell, Smita Asare, Meredith Buxton, A. Jo Chien, Hyo S. Han, Christina Yau, Jeffrey B. Matthews, Claudine J. Isaacs, Jane Perlmutter, Laura J. Esserman, Donald A. Berry, Hope S. Rugo, Anne M. Wallace, Laura J. van’t Veer
article en
1 citations

Abstract

No abstract available for this paper.
Breast Cancer Research and TreatmentVol. 209(3)
University of Minnesota (US), The University of Texas MD Anderson Cancer Center (US), University of California, San Francisco (US), Georgetown University (US), Moffitt Cancer Center (US), University of California San Diego (US), Berry & Associates (United States) (US), Quantum Leap Healthcare Collaborative (US), Mayo Clinic in Arizona (US), Gemini Computers (United States) (US), University of San Francisco (US), University of Pennsylvania (US)
Foundation for the National Institutes of Health, Breast Cancer Research Foundation, William K. Bowes, Jr. Foundation, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 34%
HER2/EGFR in Cancer Research
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.